CClinicalTrials.gg
Not yet recruitingNCT06514443COPAUpdated Jul 23, 2024

Barriers and Faciliators for Physical Activity in People With RMDs

An observational study in Osteoarthritis, Knee, Osteoarthritis, Hip and Rheumatoid Arthritis, sponsored by Anne-Kathrin Rausch. Not yet recruiting. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2024-07-23.

Sponsored by Anne-Kathrin Rausch · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 9 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
400
Ages
18 Years to 100 Years
Sex
All
01

Study summary

The aim of this project is to systematically survey and explore barriers and facilitators for the implementation of physical activity according to the physical activity recommendations of the European Alliance of Associations for Rheumatology on country specific (e.g., environmental, cultural, organization and system) level. A questionnaire to explore/identify these barriers and facilitators in the survey, will be developed through literature search, interviews with multiple stakeholders (i.e., patients with inflammatory arthritis or osteoarthritis and physical therapists) and experts in the field in four different European countries (i.e., Turkey, Switzerland, the Netherlands and France).

Additionally, in Switzerland only, the Inflammatory Arthritis Facilitators and Barriers to Physical Activity (IFAB) Questionnaire which was developed to determine the factors on personal level, will be translated into the German language. Aim is to evaluate the validity and reliability of the IFAB Questionnaire in the German-speaking population with axial Spondyloarthrits, and to perform a cultural adaptation if necessary at the same time.

02

Conditions studied

  • Osteoarthritis, Knee
  • Osteoarthritis, Hip
  • Rheumatoid Arthritis
  • Axial Spondyloarthritis
03

In context

Spondylitis

623 studies on the registry are indexed under Spondylitis; 83 are open to participants now.

This study's planned enrollment of 400 is above the median of 202 across 256 observational studies indexed under Spondylitis.

Browse Spondylitis studies →

Lead sponsor

This is the only study on the registry with Anne-Kathrin Rausch as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

people with osteoarthritis, rheumatoid arthritis or axial Spondyloarthritis living in Turkey, the Netherlands, France or Switzerland

Inclusion criteria

  • adults being 18years or older
  • diagnosis of osteoarthritis, rheumatoid arthritis or axial Spondyloarthritis
  • the cognitive and linguistic competencies to answer the survey

Exclusion criteria

Exclusion Criteria:

  • having a rheumatological or musculoskeletal disease other than described
  • any communication problems
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
400 participants (estimated)
Patient registry
No

Groups and cohorts

  • osteoarthrits

    adults with hip or knee osteoarthritis

    Other: survey

  • inflammatory arthritis

    adults with rheumatoid arthritis or axial Spondyloarthritis

    Other: survey

Interventions

  • Othersurvey

    survey exploring barriers and faciltiators for physical activity

06

What researchers measure

Primary outcomes

  1. barriers and facilitators for physical activity

    factors on social, envirionmental or system level impacting the physial activity behaviour

    Time frame: September-December 2024

Secondary outcomes

  1. reliability of the IFAB

    ONLY Swiss participants with axSpA

    Time frame: September-December 2024

  2. validity of the IFAB

    ONLY Swiss participants with axSpA

    Time frame: September-December 2024

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06514443
Lead sponsor
Anne-Kathrin Rausch
Collaborators
Acibadem University, Leiden University Medical Center, Sorbonne University
Responsible party
Anne-Kathrin Rausch (PhD, Zurich University of Applied Sciences) — Sponsor-investigator
First posted
Jul 23, 2024
Start date
Aug 1, 2024 (estimated)
Primary completion
Dec 23, 2024 (estimated)
Completion
Mar 31, 2025 (estimated)
Last update
Jul 23, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion